Image

Agility and Sprint Performance in Youth Soccer: A Comparison of FIFA 11+ and RAMP Protocols

Agility and Sprint Performance in Youth Soccer: A Comparison of FIFA 11+ and RAMP Protocols

Recruiting
8-15 years
Male
Phase N/A

Powered by AI

Overview

This randomized clinical trial investigates the comparative effects of the FIFA 11+ and RAMP (Raise, Activate, Mobilize, Potentiate) warm-up protocols on the agility and sprint performance of young soccer players. The study involves 34 male players aged 8 to 15, who will be randomly assigned to one of the two warm-up groups for a six-week intervention period. Key performance outcomes-agility, measured by the Illinois Agility Test, and sprint speed, measured by a 30-meter sprint test-will be assessed both before and after the intervention. The research aims to address a gap in sports science by directly comparing these two popular protocols in a youth population, with the goal of providing coaches with clear, evidence-based recommendations for optimizing athlete development and reducing injury risk. Data will be analyzed through SPSS version 27.00.

Description

This randomized clinical trial provides a detailed comparison of the FIFA 11+ and RAMP (Raise, Activate, Mobilize, Potentiate) warm-up protocols to determine their respective impacts on agility and sprint performance in young male soccer players. The study is grounded in the understanding that soccer requires exceptional speed and agility, and that well-structured warm-ups are critical for enhancing performance and preventing injuries, especially during the crucial developmental years of youth athletes. While both FIFA 11+ (a program focused on neuromuscular control and injury prevention) and RAMP (a systematic, four-phase preparation protocol) are widely used, there is a notable lack of research directly comparing their acute effectiveness in a youth soccer context. This study seeks to fill that gap by providing empirical evidence to guide coaches and practitioners in selecting the most effective warm-up strategy.

The study will recruit 34 male soccer players between the ages of 8 and 15, who will be randomly assigned to either the FIFA 11+ or the RAMP intervention group for a six-week period. Performance will be measured using standardized, valid, and reliable tests: the Illinois Agility Test (IAT) to assess agility and a 30-meter sprint test to measure speed. These assessments will be conducted at baseline before the intervention begins and again immediately following the six-week training period. The collected data will be analyzed to compare within-group improvements and between-group differences, with statistical adjustments for baseline values to ensure a robust comparison. The findings are expected to offer practical, evidence-based recommendations for optimizing warm-up routines to specifically enhance agility and sprint capabilities in young soccer players, thereby supporting superior athletic development. Data will be analyzed through SPSS version 27.00.

Eligibility

Inclusion Criteria:

  • Male, aged 8-15 years.
  • Minimum one year of organized soccer experience.
  • Currently training at least three times per week.
  • Willingness to participate and provide informed consent.

Exclusion Criteria:

  • Cardiovascular, neurological, or musculoskeletal disorders.
  • Musculoskeletal injury in the past six months.
  • Participation in other structured injury prevention or strength programs.
  • Inability to complete baseline testing.

Study details
    Children
    Adult

NCT07244107

Riphah International University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.